Literature DB >> 23689195

No association between cumulative traumatic experiences and sex in risk for posttraumatic stress disorder among human immunodeficiency virus-positive adults.

Tanya Morris1, Pamela Naidoo, Karen J Cloete, Justin Harvey, Soraya Seedat.   

Abstract

This study examined the association between the type and number of traumatic experiences and the conditional risk for posttraumatic stress disorder (PTSD), stratified by sex, in human immunodeficiency virus (HIV). We evaluated 465 (114 male and 350 female) HIV-positive adults attending HIV clinics in Cape Town, South Africa. Demographic and clinical data were collected, and the participants were screened for current PTSD and traumatic event exposure using the Mini-International Neuropsychiatric Interview and the Life Events Checklist, respectively. The highest attributable risk for PTSD was derived from sexual assault (17.4%) and transport accidents (16.9%). Only sexual assault was significantly (p = 0.002) associated with current PTSD. Although sex had no effect on the prediction of current PTSD, HIV-infected men tended to experience more lifetime traumas than HIV-infected women, with the men having significantly higher rates of exposure than women to physical assault (p = 0.018) and assault with a weapon (p = 0.001). These data highlight the importance of considering trauma type in contributing to the burden of PTSD in HIV-infected adults.

Entities:  

Mesh:

Year:  2013        PMID: 23689195     DOI: 10.1097/NMD.0b013e31829482d7

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  2 in total

1.  A rapid appraisal of the status of mental health support in post-rape care services in the Western Cape.

Authors:  Naeemah Abrahams; Aník Gevers
Journal:  S Afr J Psychiatr       Date:  2017-01-26       Impact factor: 1.550

2.  Type and severity of intimate partner violence and its relationship with PTSD in HIV-infected women.

Authors:  Fatima Hansrod; Georgina Spies; Soraya Seedat
Journal:  Psychol Health Med       Date:  2014-10-10       Impact factor: 2.423

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.